Trials / Completed
CompletedNCT00404001
Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia
A Phase 2, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Range-Finding Study of the Safety and Efficacy of Orally Administered MD-0727 in Patients With Primary Hypercholesterolemia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Ironwood Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objectives of this study are to evaluate the safety of MD-0727 in patients with primary hypercholesterolemia and to determine the low density lipoprotein cholesterol (LDL-C) lowering effect and dose-response of MD-0727 in patients with primary hypercholesterolemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MD-0727 |
Timeline
- Start date
- 2006-11-01
- Completion
- 2007-07-01
- First posted
- 2006-11-27
- Last updated
- 2007-10-01
Locations
20 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00404001. Inclusion in this directory is not an endorsement.